FDA recall, , Moderate risk
Mito Red Light Super Mobile
The near-infrared therapy device contains a lithium-ion battery that may malfunction, causing it to catch fire or burst into flames.
Summary by Recall Canary from the FDA notice
What happened
MITO RED LIGHT INC of Scottsdale, Arizona, recalled its Mito Red Light, Super Mobile near-infrared therapy device on February 12, 2025, because the lithium-ion battery may malfunction, causing it to catch fire or burst into flames. The recall was added to the FDA's Enforcement Report on June 17, 2026.
The device was distributed worldwide, including nationwide in the United States and in Australia, Canada, China, Japan, New Zealand, Spain, Switzerland, United Arab Emirates, and the United Kingdom.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:
- A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
- Talk to your health care provider before you stop using it.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Mito Red Light, Super Mobile
Recall details
- Company began the recall
- Sold in
Worldwide - US Nationwide distribution including in the states of Alabama, Arkansas, Arizona, California, Colorado, Connecticut, District of Columbia, Delaware, Florida, Georgia, Hawaii, Iowa, Idaho, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, NL, New Mexico, Nevada, New York, Ohio, Oregon, Pennsylvania, PR, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Vermont, Washington, Wisconsin, West Virginia and the countries of Australia, Canada, China, Japan, New Zealand, Spain, Switzerland, United Arab Emirates, United Kingdom.
- Company
- MITO RED LIGHT INCScottsdale, Arizona
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98999
- Recall number
- Z-2478-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
In FDA's weekly enforcement report
Listed on Recall Canary
